These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30048979)

  • 1. The Effect of Metformin on the Endometrium of Women with Polycystic Ovary Syndrome.
    Dragamestianos C; Messini CI; Antonakis PT; Zacharouli K; Kostopoulou E; Makrigiannakis A; Georgoulias P; Anifandis G; Dafopoulos K; Garas A; Daponte A; Messinis IE
    Gynecol Obstet Invest; 2019; 84(1):35-44. PubMed ID: 30048979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome.
    Zhai J; Liu CX; Tian ZR; Jiang QH; Sun YP
    Biol Reprod; 2012 Aug; 87(2):29. PubMed ID: 22572996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline personality disorder and polycystic ovary syndrome.
    Trisno R; Worsley R; Kulkarni J
    Aust N Z J Psychiatry; 2016 Apr; 50(4):385. PubMed ID: 26553218
    [No Abstract]   [Full Text] [Related]  

  • 4. Metformin reduces androgen receptor and upregulates homeobox A10 expression in uterine endometrium in women with polycystic ovary syndrome.
    Ohara M; Yoshida-Komiya H; Ono-Okutsu M; Yamaguchi-Ito A; Takahashi T; Fujimori K
    Reprod Biol Endocrinol; 2021 May; 19(1):77. PubMed ID: 34053455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin reduces the expression of corticotropin-releasing hormone and urocortin in the endometrium of healthy women.
    Dafopoulos K; Vrekoussis T; Chalvatzas N; Messini CI; Kalantaridou SN; Georgoulias P; Messinis IE; Makrigiannakis A
    Fertil Steril; 2013 Nov; 100(5):1405-9. PubMed ID: 23987517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Metformin on endometrial tumor-regulatory genes and systemic metabolic parameters in polycystic ovarian syndrome--a proof-of-concept study.
    Shafiee MN; Malik DA; Yunos RI; Atiomo W; Omar MH; Ghani NA; Hatta AZ; Seedhouse C; Chapman C; Mokhtar NM
    Gynecol Endocrinol; 2015 Apr; 31(4):286-90. PubMed ID: 25495168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metformin on endocrine, metabolic milieus and endometrial expression of androgen receptor in patients with polycystic ovary syndrome.
    Ito-Yamaguchi A; Suganuma R; Kumagami A; Hashimoto S; Yoshida-Komiya H; Fujimori K
    Gynecol Endocrinol; 2015 Jan; 31(1):44-7. PubMed ID: 25237893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metformin treatment on endometrial vascular indices in anovulatory obese/overweight women with polycystic ovarian syndrome using three-dimensional power doppler ultrasonography.
    Mohsen IA; Elkattan E; Nabil H; Khattab S
    J Clin Ultrasound; 2013 Jun; 41(5):275-82. PubMed ID: 23124626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome.
    Palomba S; Russo T; Orio F; Falbo A; Manguso F; Cascella T; Tolino A; Carmina E; Colao A; Zullo F
    Hum Reprod; 2006 Feb; 21(2):457-65. PubMed ID: 16253975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin.
    Cui N; Feng X; Zhao Z; Zhang J; Xu Y; Wang L; Hao G
    Clin Ther; 2017 Apr; 39(4):751-758. PubMed ID: 28291580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.
    Palomba S; Falbo A; Zullo F; Orio F
    Endocr Rev; 2009 Feb; 30(1):1-50. PubMed ID: 19056992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome.
    Legro RS; Zaino RJ; Demers LM; Kunselman AR; Gnatuk CL; Williams NI; Dodson WC
    Am J Obstet Gynecol; 2007 Apr; 196(4):402.e1-10; discussion 402.e10-1. PubMed ID: 17403436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis.
    Yuan L; Wu H; Huang W; Bi Y; Qin A; Yang Y
    Reprod Biol Endocrinol; 2021 Jun; 19(1):89. PubMed ID: 34127011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled preparation of the endometrium with exogenous estradiol and progesterone in women having functioning ovaries.
    de Ziegler D; Cornel C; Bergeron C; Hazout A; Bouchard P; Frydman R
    Fertil Steril; 1991 Nov; 56(5):851-5. PubMed ID: 1936317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome.
    Sahin Y; Yirmibeş U; Keleştimur F; Aygen E
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):214-20. PubMed ID: 15063963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
    Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
    Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Metformin and Carbohydrate-Controlled Diet on DNA Methylation and Gene Expression in the Endometrium of Women with Polycystic Ovary Syndrome.
    García-Gómez E; Gómez-Viais YI; Cruz-Aranda MM; Martínez-Razo LD; Reyes-Mayoral C; Ibarra-González L; Montoya-Estrada A; Osorio-Caballero M; Perichart-Perera O; Camacho-Arroyo I; Cerbón M; Reyes-Muñoz E; Vázquez-Martínez ER
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.